Literature DB >> 7913176

Polyarteritis nodosa and parvovirus B19.

M Leruez-Ville, A Laugé, F Morinet, L Guillevin, P Dény.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7913176     DOI： 10.1016/s0140-6736(94)93030-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Management of virus-induced systemic vasculitides.

Authors:  Loïc Guillevin; Pascal Cohen
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 2.  Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations.

Authors:  Laura B Hughes; S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 3.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

4.  No evidence of parvovirus B19 in tissue samples from patients with polyarteritis nodosa and microscopic polyangiitis as assessed by the polymerase chain reaction.

Authors:  Z Sachetto; S C B Costa; P D Andrade; R A Conde; E M I Amstalden; A M Samara; S R M Fernandes
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

5.  Molecular evidence of parvovirus B19 in the cutaneous polyarteritis nodosa tissue from a patient with parvovirus-associated hemophagocytic syndrome: Case report.

Authors:  Ji Yun Jeong; Ji Young Park; Ji Yeon Ham; Ki Tae Kwon; Seungwoo Han
Journal:  Medicine (Baltimore)       Date:  2020-09-04       Impact factor: 1.889

6.  Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia.

Authors:  P Cacoub; N Boukli; P Hausfater; A Garbarg-Chenon; P Ghillani; V Thibault; L Musset; J M Huraux; J C Piette
Journal:  Ann Rheum Dis       Date:  1998-07       Impact factor: 19.103

Review 7.  [Vasculitis associated with viral infections].

Authors:  Pascal Cohen; Loïc Guillevin
Journal:  Presse Med       Date:  2004-11-06       Impact factor: 1.228
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.